stella
beta
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures — Stella
Recruiting
Back to Focal Epilepsy trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(7 sites)
United States
Consultants in Epilepsy and Neurology, PLLC, Boise, Idaho
Mayo Clinic, Rochester, Minnesota
NYU Langone Comprehensive Epilepsy Center, New York, New York
Cleveland Clinic Foundation, Cleveland, Ohio
University of Pennsylvania - Department of Neurology, Philadelphia, Pennsylvania
Show all 7 locations
View full record on ClinicalTrials.gov